DRKS00024872
Recruiting
Not Applicable
Characterization of biomarkers to identify responders and non-responders in chronic spontaneous urticaria (CSU) therapy
Klinik für DermatologeElbekliniken Stade-Buxtehude0 sites50 target enrollmentMarch 19, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic spontaneous urticaria
- Sponsor
- Klinik für DermatologeElbekliniken Stade-Buxtehude
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with spontaneous urtikatia who are eligible for omalizumab therapy.
Exclusion Criteria
- •Subjects younger than 18 years and older than 65 years.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Development and evaluation of diagnostic biomarker panels on the basis of microarray analysis for treatment planning of oral squamous cell carcinomaoral squamous cell carcinomaC06.9Mouth, unspecifiedDRKS00000199Pro Inno IIAiF Projekt GmbH80
Recruiting
Not Applicable
Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in pancreatic cancer and biliary tract cancerPancreatic cancer Biliary tract cancerJPRN-UMIN000044430MiRTeL Co.Ltd.100
Recruiting
Not Applicable
Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in head and neck cancerHead and neck cancerJPRN-UMIN000042276ational Cancer Center Hospital East475
Recruiting
Not Applicable
Validation of specific biomarkers for the diagnosis of endometriosisNL-OMON49755198865
Completed
Not Applicable
Identification of biomarkers specific to different nicotine product categoriessmokingDRKS00022428ABF GmbH60